Oncology Provider Profiles analyze population, access, control and payment dynamics for the largest hospital and community-based practices treating cancer. The profiles provide a combination of
Oncology Provider Profiles analyze population, access, control and payment dynamics for the largest hospital and community-based practices treating cancer. The profiles provide a combination of
Health insurers in Oregon and Washington are trying to meet demand for more cost-effective products as the economy struggles and healthcare costs rise. In Washington, Blue Cross and Blue Shield of Ill…
Private and Medicare plans will continue their receptiveness to oral oncology therapies over the next five years, but anticipated increases in coinsurance rates and copays will shift more of the cost…
Commercial markets in Colorado and Nevada have been shaken up by expansion of HMOs and, in the case of Las Vegas, new market entrants. At the same time, local brokers say employers are not likely to s…
While we forecast sales of oncology drugs in the United States to grow at a compound annual growth rate of 4.4% between now and 2016, we forecast sales of monoclonal antibodies (MAbs) in oncology to g…
Formulary Advantages in Orally Delivered Oncology Agents: Impact of Cost Controls and Emerging Agents on Key Brands